Creation of a database linking EEG recordings with clinical information for epilepsy patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project aims to create a pilot database that combines de-identified EEG recordings and clinical information from patients referred to the UNMH Comprehensive Epilepsy Center. The database will facilitate the correlation of neurobiomarkers with treatment outcomes, enhancing seizure localization and potentially leading to new algorithms for predicting seizure activity. The initial phase will involve collecting demographic data and clinical reports, with future expansions planned to include additional imaging data and detailed seizure annotations. This comprehensive database will serve as a valuable resource for advancing epilepsy treatment and research.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* We will screen with UNMH EEG database, Nihon Kohden Neuroworkbench first. After meeting all the inclusion and exclusion criteria, we will access the Cerner Powerchart (UNMH EMR) for the rest of the clinical information.
* 18 years old or older. If the patient's age is over 89, we will aggregated them to age 90 or older so that the patient cannot be identified. Also, all the EEG data will be de-identified and only show the year of the study performed instead of the exact study date to reduce the risk of identification. Of note, we perform over few thousands of EEG studies per year and it will be almost impossible to identify the patient based on the study year.

Exclusion Criteria:

* Children under age of 18 years old will be excluded.
* Mismatched patients between EEG database and EMR

Where it's running

• University of New Mexico Health Science
  Albuquerque, New Mexico, United States Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Levetiracetam to prevent seizures in adults with Down syndrome and Alzheimer's disease

  This trial will test whether the anti-seizure medicine levetiracetam can prevent tonic-clonic seizures and slow cognitive decline in adults over 40 who have Down syndrome and symptomatic Alzheimer's disease.

  Recruiting Phase 3 Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau · Granada, Andalusia and 4 other locations · NCT07234695

• Wearable device for detecting seizures

  This study tests a new wearable device for detecting seizures in people with epilepsy to see if it works well and can help them feel more comfortable in their daily lives.

  Recruiting at 2 sites University of Massachusetts, Worcester · Worcester, Massachusetts and 1 other locations · NCT06598189

• Using perampanel to prevent seizures after cardiac arrest

  This study is testing if the medication perampanel can help prevent seizures in patients who have survived a cardiac arrest and are in a coma.

  Recruiting Phase 2 University of California, San Francisco · San Francisco, California · NCT06401707

• Investigating factors that lead to epilepsy after a stroke

  This study is trying to find out what factors might cause epilepsy in people who have had a stroke by comparing them to healthy individuals.

  Recruiting Norwegian University of Science and Technology · Trondheim · NCT05864547

• Using EEG to guide anesthesia for seizures after cardiac arrest

  This study is testing two different ways of using EEG to guide anesthesia in patients who have had a cardiac arrest and are experiencing severe seizures, to see which method works better at controlling those seizures.

  Recruiting Phase 2 University of California, San Francisco · San Francisco, California · NCT05851391

• Effects of scopolamine on brain activity related to memory in epilepsy patients

  This study is testing if the drug scopolamine can change how well people with epilepsy remember things by looking at their brain activity while they do memory tasks.

  Recruiting Early Phase 1 University of Texas Southwestern Medical Center · Dallas, Texas · NCT05594017

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.